Earth's board reads Meridian's clean cohort and reserves judgment on the one it can't see

MERIDIAN — Earth's longevity therapy board began reading Meridian's data this week, and the first thing its auditors did was ask for the one file they'd already been told they couldn't have. That's not a bad instinct. It's the only instinct doctors are supposed to have.

The dataset the colony's directorate released under this week's transparency framework is, by every account, tidy. Biomarkers, dosing schedules, observation windows, agreed definitions of harm, across all four cohorts. The second cohort of 208 completed a full observation month with clean panels and no reported adverse events. The third finished the same way. Numbers don't usually behave this well. (A chart with no bad days isn't reassuring. It's a chart someone edited, or a chart nobody's kept long enough to embarrass.)

What the board can't see is a nine-page case file on a retired desalination engineer from the first cohort of 140, admitted to observation with an unexplained fever and sealed under Meridian's retained authority to classify patient records. Everything else opened. That one didn't.

"We were given a dataset we did not design, describing patients we have never examined, in a facility we have never entered," said Dr. Adaeze Okonkwo, who chairs the board's review. "They have asked us to certify the health of a program from its own paperwork. The one record that would tell us how the program handles a problem is the record they kept."

Meridian's directorate calls the same fact sovereignty, not concealment. "We shared a dataset we built to standards we set," said Health Director Túlio Vasquez, speaking from the colony's medical commons. "Sharing it cedes nothing. The engineer is our citizen, and her file is classified under our law, not withheld under Earth's suspicion. Earth is welcome to audit what we chose to open. It is not owed what we chose to seal."

That's the whole argument, really, compressed into two sentences at a podium. The board thinks a therapy isn't the sum of its clean months. It's what happens on the bad day, and the bad day is exactly what's sealed. Meridian thinks Earth has no standing to audit a treatment it's never watched in person, and no standing to relitigate a colony's medical sovereignty over one fever.

Neither position moves the calendar. A fourth cohort of 139 paying passengers is scheduled to depart in sixty-one days. Tickets bought, transfer window fixed. Those passengers will arrive whether or not the board reaches a finding, which puts the review, clinically speaking, behind the disease.

One board auditor, granted anonymity because the review is ongoing, put it plainly. "We can validate the cohorts we can see. We can say the biomarkers are consistent and the harm definitions are reasonable. We cannot say the program is safe, because safe is a word about the case they closed."

Dr. Okonkwo wouldn't say when the board expects to rule. Asked whether a clean dataset with one sealed file could earn Earth's endorsement, she didn't answer directly. "The panels are clean," she said. "The chart tells a different story about what clean is worth when you don't get to read the whole chart."